Search Results | Clear Search | Previous (in doc) | Next (in doc) | Prev Doc | Next Doc
B.C. Reg. 4/83
O.C. 6/83
Filed January 11, 1983
This archived regulation consolidation is current to August 31, 2007 and includes changes enacted and in force by that date. For the most current information, click here.

Health Act

Health Act Communicable Disease Regulation

[includes amendments up to B.C. Reg. 115/2007, May 11, 2007]

Contents
Interpretation
Part 1 — Reports
Reportable disease
Reports by hospital
Contents of report
Report of action taken
Verification of reports
6.1  Voluntary testing
6.2  Index patient
6.3  West Nile Virus testing disclosure
Part 2 — Isolation and Quarantine
Isolation of infected person
Quarantine of susceptible person
Release by medical health officer
10  Posting of notice
11  Removal of articles from quarantine
Part 3 — Examination and Treatment
12  Compulsory examination and treatment
13  Specific control measures
Part 4 — Handling of Dead Bodies
14  Handling body where death from anthrax, plague or viral hemorrhagic fever
15  Transportation of dead body
16  Valid transit certificate
Part 5 — General
17  Treatment of baby's eyes at birth
18  Order of closure of public place
19  Contaminated pet food
20  Section 11 (4) (e) of the Act

Interpretation

1  In this regulation:

"carrier" means a person who harbours, and who may disseminate, a specific infectious agent in the absence of discernible clinical disease;

"communicable disease" means an illness, due to a specific infectious agent or its toxic products, which arises through the transmission of that agent or its product

(a) directly from an infected person or animal, or

(b) indirectly through the agency of an intermediate host vector or the inanimate environment;

"contact" means a person who has been or is in association with an infected person or animal, or with a contaminated environment, and has had an opportunity of acquiring the infection;

"epidemic" means an occurrence of a disease within a community or region in excess of normal expectancy;

"food handler" means a person engaged in the preparation, manufacture, storage, serving or sale of food or drink where the food or drink itself is handled, but does not include a person who only handles completely packaged food or drink;

"infectious agent" means an organism capable of producing an infection or infectious disease;

"isolation" means the separation, for the period of communicability of the disease, of an infected person or animal from others in a place and under conditions to prevent the conveyance of the infectious agent to those others;

"laboratory" means a medical or clinical diagnostic facility, and for the purposes of section 2 (3) includes the Animal Health Centre, Ministry of Agriculture and Lands, Abbotsford, British Columbia;

"modified isolation" means

(a) the restriction of the infected person to his residence and the grounds surrounding his residence, or

(b) the limitation of freedom of movement of the infected person that is necessary in the opinion of the medical health officer or physician, as the case may be;

"physician" means a duly qualified medical practitioner;

"quarantine" means the limitation of freedom of movement of a susceptible person or domestic animal, suspected of being or known to have been exposed to a communicable disease, for a period of time equal to the longest usual incubation period of that disease from the last date of exposure;

"reportable communicable disease" means a disease

(a) listed in Schedule A or B, or

(b) which becomes epidemic or shows unusual features;

"strict isolation" means the complete segregation, in a room used for no other purpose, of an infected person from all persons except

(a) the physicians and nurses in attendance, and

(b) those persons authorized by the medical health officer;

"susceptible person" means a person not possessing adequate resistance against a specific infectious agent.

[am. B.C. Reg. 43/2007, s. (a).]

Part 1 — Reports

Reportable disease

2  (1)  Where a person knows or suspects that an animal or another person is suffering from or has died from a communicable disease, he shall, without delay, make a report to the medical health officer.

(2)  Where a physician knows or suspects that an animal or another person is suffering from or has died from a communicable disease, he shall, without delay and in accordance with section 4, make a report to the medical health officer if the disease

(a) is listed in Schedule A, or

(b) becomes epidemic or shows unusual features.

(3)  Where a person in charge of a laboratory knows or suspects, as a result of analysis, examination or tests of or on a specimen, that an animal or another person is suffering from or has died from a communicable disease listed in Schedule B, he shall, within 7 days and in accordance with section 4, make a report to the medical health officer.

(4)  The medical health officer shall forward a report received under this section, within 7 days of receiving it, to the Provincial health officer, together with any further information requested by the Provincial health officer.

(5)  A report required to be made without delay shall be made by telephone or by any similar rapid means of communication.

Reports by hospital

3  In addition to the requirements of section 2, the administrator or other person in charge of a hospital shall, within 7 days, make a report to the medical health officer respecting a patient admitted to the hospital who is suffering from a reportable communicable disease or from rheumatic fever.

Contents of report

4  (1)  A report made under section 2 (2) shall include

(a) the name of the disease,

(b) the name, age, sex and address of the infected person, and

(c) appropriate details if the disease reported is epidemic or shows unusual features.

(2)  A report made under section 2 (3) shall include

(a) the name of the disease,

(b) the name and address of the person from whom the specimen was taken, and

(c) the name and address of the physician or other person who is or has been attending the person referred to in paragraph (b).

(3)  A report made under section 3 shall include

(a) the name of the disease,

(b) the name, age, sex and address of the patient, and

(c) the name and address of the physician or other person who is or has been attending the patient.

(4)  All reports referred to in this section shall include any further relevant information requested by the medical health officer.

(5)  A report made under section 2 (2) or (3) or 3 respecting a person who voluntarily submitted to testing for Human Immunodeficiency Virus must omit the name and address of the person if that person so chooses.

[am. B.C. Reg. 62/2003, s. (b).]

Report of action taken

5  Where a physician, who knows or suspects that a person is infected with a reportable communicable disease, orders isolation or quarantine under this regulation, he shall immediately notify the medical health officer of the action taken.

Verification of reports

6  The medical health officer shall verify all reports that a person is infected with a reportable communicable disease before ordering or continuing isolation, quarantine or any other control measures respecting that person.

Voluntary testing

6.1  Where a person voluntarily submits himself to testing or examination for a communicable disease and, as a result of that voluntary test, another person is required to make a report to the medical health officer under section 2 or 3, no person shall disclose or permit to be disclosed to any person other than the medical health officer information contained in the report or the results of an examination or test, without the written consent of the person who so volunteered.

[en. B.C. Reg. 8/86.]

Index patient

6.2  (1)  In this section:

"index patient" means a person known or suspected to be suffering from, or who has died from, a communicable disease;

"relevant information" includes any information that may, directly or indirectly, identify the index patient.

(2)  Despite sections 4 (5) and 6.1,

(a) a physician who reasonably believes that another person may be at risk of harm from an index patient may provide any relevant information to the medical health officer, and

(b) on receiving information from a physician under paragraph (a), the medical health officer may

(i)  request further relevant information from the physician,

(ii)  require the index patient to undergo further examination and to provide further relevant information, and

(iii)  disclose to any person who may be at risk of harm any relevant information the medical health officer feels necessary to address the harm or to prevent further harm.

[en. B.C. Reg. 62/2003, s. (c).]

West Nile Virus testing disclosure

6.3  (1)  The Provincial Health Officer may direct the British Columbia Centre for Disease Control to disclose relevant personal information identifying the source of blood samples being tested for West Nile Virus at its laboratory to the Canadian Blood Services agency.

(2)  The Provincial Health Officer must only authorize the disclosure of information in subsection (1) for use by the Canadian Blood Services agency

(i)  to determine whether it had received a donation of blood from those persons and to suspend distribution of that donated blood pending the results of laboratory analysis, and

(ii)  to determine whether it had provided those persons with donated blood.

(3)  This section is repealed May 21, 2008.

[en. B.C. Reg. 223/2004; am. B.C. Reg. 182/2005; 84/2006; 115/2007.]

Part 2 — Isolation and Quarantine

Isolation of infected person

7  The medical health officer or a physician may order a person, whom he knows or suspects to be suffering from a reportable communicable disease, to be placed in strict or modified isolation.

Quarantine of susceptible person

8  The medical health officer or a physician may order a susceptible person, who is a contact of a person suffering from a reportable communicable disease, to be placed in quarantine.

Release by medical health officer

9  The medical health officer may release a person placed in isolation or quarantine by a physician if, in his opinion, the signs or symptoms of the illness are not consistent with a diagnosis of the reportable communicable disease.

Posting of notice

10  (1)  The medical health officer may sign and post the notice, set out in Schedule C, in a conspicuous place at the entrance to any premises where a person under quarantine is living.

(2)  No person shall interfere with or obstruct a medical health officer, or anyone authorized by him, from posting the notice.

(3)  No person shall remove a posted notice except by permission of the medical health officer, or conceal or mutilate it.

(4)  In the event that the posted notice is removed, concealed or mutilated, the occupant of the premises on which the notice was posted shall, without delay, notify the medical health officer.

Removal of articles from quarantine

11  No person shall, without the written consent of the medical health officer, remove or permit to be removed

(a) any article from premises where a person under isolation or quarantine is living, or

(b) any milk or milk products from a farm or dairy where a person, suffering from or a carrier of salmonellosis or campylobacteriosis, or other reportable communicable disease which may be spread by raw milk, is living, unless the milk or milk products are to be pasteurized before distribution or use.

Part 3 — Examination and Treatment

Compulsory examination and treatment

12  (1)  Where a medical health officer knows or suspects that a person is infected with a reportable communicable disease, he may, by notice, direct that person to

(a) undergo medical examinations by a physician designated by the medical health officer,

(b) permit the collection of specimens of his blood, spinal fluid, sputum, stool, urine, gastric washings or exudate,

(c) have X-rays taken as required by the medical health officer for examination and interpretation to determine if he is so infected, and

(d) undergo treatment that, in the opinion of the medical health officer, is necessary, whether or not the diagnosis is supported by laboratory evidence of infection,

within a specified time.

(2)  The medical health officer shall give the notice

(a) by delivering it in person or by an authorized representative, or

(b) by registered mail.

(3)  The medical health officer shall send a copy of the notice to the Provincial health officer.

(4)  On the request of the medical health officer, a person shall send or cause to be sent

(a) a specimen of blood, spinal fluid, sputum, stool, urine, gastric washings, exudate or other bodily discharge, collected for the diagnosis or control of a reportable communicable disease, to the Division of Laboratories, Ministry of Health, for examination and testing, and

(b) X-rays, made for the diagnosis or control of tuberculosis, to the Division of Tuberculosis Control, Ministry of Health, for examination and interpretation.

(5)  A laboratory report from the Division of Laboratories, or an X-ray report from the Division of Tuberculosis Control, shall be evidence of the results of the examination and tests performed by the Division of Laboratories or the interpretation of the X-ray by the Division of Tuberculosis Control.

(6)  No person shall disclose the results of an examination, test or interpretation made under subsection (1) or (4) to any person other than a medical health officer, a public health inspector, a public health nurse or a physician.

Specific control measures

13  Where a medical health officer or a physician knows or suspects that a person or animal is suffering from a disease listed in Schedule D, he shall ensure that the isolation procedures, quarantine and special measures set out in that Schedule for the disease are included in the treatment of the infected person or animal and in the control measures taken respecting the disease.

Part 4 — Handling of Dead Bodies

Handling body where death from anthrax, plague or viral hemorrhagic fever

14  (1)  Where a funeral director, or other person, is requested to handle the body of a person who died from anthrax, plague or viral hemorrhagic fever, he shall immediately report the request to the medical health officer.

(2)  Subject to any directions that the medical health officer may give respecting the handling of the body, the funeral director or other person shall wrap and securely seal the body in heavy plastic sheeting before removing it from the room in which death occurred, place it wrapped and sealed in a casket, immediately close the casket and not permit the casket to be reopened.

Transportation of dead body

15  A person who transports a dead body must do so in a manner that does not cause a health hazard.

[en. B.C. Reg. 2/2006.]

Valid transit certificate

16  (1)  No person shall ship a dead body by rail, air, ship or truck without a valid transit certificate.

(2)  A properly completed burial permit, issued under the Vital Statistics Act, attached to the head of the box containing the casket constitutes a valid transit certificate.

Part 5 — General

Treatment of baby's eyes at birth

17  (1)  A physician, or other qualified person, assisting at the birth of a baby must within one hour of the birth treat the eyes of the baby with a prophylactic solution of 1% tetracycline, 0.5% erythromycin, or 1% silver nitrate dispensed in single use containers.

(2)  Subsection (1) does not apply if both parents or, if the father is not available, the mother give a written statement directing that subsection (1) not be followed in the case of their baby.

(3)  Before accepting a written statement under subsection (2), the physician or other qualified person assisting at the birth must inform the parents, or mother, as the case may be,

(a) why the treatment is recommended,

(b) what advantages should be anticipated from the treatment,

(c) what problems may arise if the treatment is not given, and

(d) what side effects may arise from the treatment.

[en. B.C. Reg. 254/95.]

Order of closure of public place

18  A medical health officer may order a publicly or privately operated school, public swimming pool, bathing beach, theatre, recreation hall or any other public gathering place to be closed for the purpose of controlling the spread of a communicable disease.

Contaminated pet food

19  No person shall offer for sale or sell as pet food meat containing micro-organisms capable of producing disease in humans.

Section 11 (4) (e) of the Act

20  A hospital, institution or other place listed in Schedule E is designated as a place for the purposes of section 11 (4) (e) of the Act.

[en. B.C. Reg. 181/88, s. 4.]

 

Schedule A

[am. B.C. Regs. 31/85; 189/94; 394/94; 45/96; 267/96, s. 1; 380/97; 147/98; 54/2000; 282/2000;
283/2000; 87/2001; 217/2001; 146/2002; 62/2003, s. (a); 155/2003; 244/2003; 43/2007, s. (b); 44/2007.]

List of Reportable Communicable Diseases

[reportable by all sources — section 2 (2)]

Acquired Immune Deficiency Syndrome
Anthrax
Botulism
Brucellosis
Cholera
Congenital infections:
  Toxoplasmosis, Rubella, Cytomegalovirus, Herpes Simplex, Varicella-zoster, Hepatitis B Virus,
Listeriosis and any other congenital infection
Creutzfeldt-Jacob Disease
Cryptococcus neoformans
Cryptosporidiosis
Cyclospora Infection
Diffuse Lamellar Keratitis (DLK)
Diphtheria:
  Cases
Carriers
Encephalitis:
  Post-infectious
Subacute sclerosing panencephalitis
Vaccine-related
Viral
Foodborne illness:
  All causes
Gastroenteritis epidemic:
  Bacterial
Parasitic
Viral
Genital Chlamydia Infection
Giardiasis
H5 and H7 strains of the Influenza virus
Haemophilus Influenzae Disease,
  All Invasive, by Type
Hantavirus Pulmonary Syndrome
Hemolytic Uremic Syndrome
Hemorrhagic Viral Fevers
Hepatitis Viral:
  Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis E
Other Viral Hepatitis
Human Immunodeficiency Virus
Invasive Group A Streptococcal Disease
Invasive Streptococcus Pneumoniae Infection
Leprosy
Lyme Disease
Measles
Meningitis: All causes
  (i) Bacterial:
 Hemophilus
 Pneumococcal
 Other
  (ii) Viral
Meningococcal Disease:
  All Invasive
Including Primary Meningococcal Pneumonia and Primary Meningococcal Conjunctivitis
Mumps
Neonatal Group B Streptococcus Infection
Paralytic Shellfish Poisoning (PSP)
Pertussis (Whooping Cough)
Plague
Poliomyelitis
Rabies
Reye's Syndrome
Rubella:
  Congenital Rubella Syndrome
Severe Acute Respiratory Syndrome
Smallpox
Tetanus
Transfusion Transmitted Infection
Tuberculosis
Tularemia
Typhoid Fever and Paratyphoid Fever
Venereal Disease:
  Chancroid
Gonorrhea - all sites
Syphilis
Waterborne Illness:
  All causes
West Nile Virus Infection
Yellow Fever

 

Schedule B

[am. B.C. Regs. 267/96 s. 2; 146/2002; 62/2003, s. (a); 155/2003; 244/2003; 410/2003; 43/2007, s. (c); 44/2007.]

List of Reportable Communicable Diseases

[reportable by laboratories only — section 2 (3)]

All specific bacterial and viral stool pathogens:
  (i) Bacterial:
    Campylobacter
Salmonella
Shigella
Yersinia
  (ii) Viral
Amoebiasis
Borrelia burgdorferi Infection
Cerebrospinal Fluid Micro-organisms
Chlamydial Diseases, including Psittacosis
Creutzfeldt-Jacob Disease
Cryptococcus neoformans
Herpes Genitalis
Human Immunodeficiency Virus
Influenza virus, including the H5 and H7 strains
Legionellosis
Leptospirosis
Listeriosis
Malaria
Q Fever
Rickettsial Diseases
Severe Acute Respiratory Syndrome
Smallpox
Tularemia
West Nile Virus Infection

 

Schedule C

Notice of Quarantine

[Section 10 (1)]

Communicable Disease Quarantine

All persons within these premises are under quarantine. No one shall enter, leave or remove any article from these premises without the written consent of the medical health officer. Any person removing this notice without permission from the medical health officer is liable to a fine not exceeding $500 or to imprisonment for a term not exceeding 6 months, or to both a fine and imprisonment, and each day the offence continues constitutes a separate offence.

........................................................................................
Medical Health Officer

 

Schedule D

Specific Control Measures

[Section 13]

1 Anthrax
Isolation procedures: strict isolation.
Quarantine: none.

Special measures: An animal suspected of having anthrax shall be isolated under the care of a veterinarian, and the Health of Animals Division of the Canada Department of Agriculture shall be immediately notified. The animal shall be disposed of in accordance with the instructions of Health of Animals Division.

2 Chickenpox
Isolation procedures: none.
Quarantine: none.

Special measures: An infected person shall be excluded from school from the time the eruption first appears until the skin lesions become crusted or for 6 days after onset of illness, whichever is the longer.

3 Cholera
Isolation procedures: enteric isolation for the duration of illness.
Quarantine: none.

Special measures: A contact shall be kept under surveillance for 5 days from his last exposure.

4 Diphtheria
Isolation procedures: Respiratory or wound isolation, as appropriate, shall apply until

(a) 2 cultures taken 24 hours apart, and not less than 24 hours after the cessation of antimicrobial therapy, fail to show diphtheria bacilli, or

(b) 14 days from the onset of disease if cultures are not available.

Quarantine: none.

Special measures: A contact shall not be permitted to place new groups at risk, but need not be excluded from groups already exposed, pending culture results or as determined by the medical health officer.

5 Hepatitis A
Isolation procedures: Enteric isolation procedures shall apply for 14 days from the onset of illness or for 7 days after the onset of jaundice, whichever is the longer.
Quarantine: none.

Special measures:

(1) An infected person shall be excluded from occupations involving the handling of food or milk for 28 days from the onset of the illness, unless it has been demonstrated that the person possesses antibodies against the hepatitis A virus.

(2) A contact shall be excluded from occupations involving the handling of food or milk, unless

(a) the milk or milk products will be pasteurized from the 14th day to the 35th day after contact, or

(b) it has been demonstrated that the contact possesses antibodies against the hepatitis A virus or has received immune globulin.

6 Hepatitis B
Isolation procedures: Blood precautions shall be taken.
Quarantine: none.

Special measures: A person known to have hepatitis B surface antigen in his blood shall be rejected as a blood donor, and blood, tissue or fluid and contaminated articles taken from that person shall be disposed of in a manner that will eliminate risk to any individual.

7 Leprosy
Isolation procedures: Cutaneous isolation procedures shall apply until the patient is on specific therapy and judged to be non-infectious by the medical health officer.
Quarantine: none.

Special measures: none.

8 Measles
Isolation procedures: none.
Quarantine: none.

Special measures: An infected person shall be excluded from school and from non-familial contact from the onset of the catarrhal stage through the third day of the rash. A susceptible child should be immunized.

9 Meningococcal Infection
Isolation procedures: Respiratory isolation procedures shall apply until 24 hours after the start of chemotherapy or until clinical recovery, whichever is the sooner.
Quarantine: none.

Special measures: The medical health officer shall place a contact under surveillance. A household contact should receive chemoprophylaxis with Rifampin.

10 Mumps
Isolation procedures: none.
Quarantine: none.

Special measures: An infected person shall be excluded from school and from non-familial contact for a period of 3 days from the onset of swelling.

11 Pertussis
Isolation procedures: Respiratory isolation procedures shall apply for a period of 3 weeks from onset of symptoms or until antibiotic therapy has been carried out, whichever is the shorter.
Quarantine: none.

Special measures: A susceptible contact of a proven case should receive chemoprophylaxis with erythromycin or other effective antibiotic.

12 Poliomyelitis
Isolation procedures: Enteric isolation procedures shall apply for one week from onset.
Quarantine: none.

Special measures: The medical health officer shall place a contact under surveillance.

13 Rubella
Isolation procedures: Modified isolation procedures shall apply only when required to protect a non-immune woman during pregnancy, especially in her first trimester.
Quarantine: none.

Special measures: A pregnant contact should be serologically tested for susceptibility.

14 Salmonellosis
Isolation procedures: Enteric isolation procedures shall apply during the period of diarrhea.
Quarantine: none.

Special measures:

(1) An infected person shall be excluded from occupations involving the handling of food or milk, or the care of children, the sick, elderly or dependent, until 2 stool specimens from the infected person, taken not less than 24 hours apart and no sooner than 48 hours after the cessation of chemotherapy, are reported as negative by a microbiologist, unless the sanitary habits of the individual lead the medical health officer to decide that risk of transmission is low.

(2) A contact shall be excluded from occupations involving the handling of food or milk, or the care of children, the sick, elderly or dependent, until 2 stool specimens from the contact, taken not less than 24 hours apart, are reported as negative, unless the sanitary habits of the individual lead the medical health officer to decide that risk of transmission is low.

15 Shigellosis
Isolation procedures: Enteric isolation procedures shall be applied during the active stage of the illness.
Quarantine: none.

Special measures:

(1) An infected person shall be excluded from occupations involving the handling of food or milk, or the care of children, the sick, elderly or dependent, until 2 stool specimens from the infected person, taken not less than 24 hours apart and no sooner than 48 hours after the cessation of chemotherapy, are reported as negative by a microbiologist, unless the sanitary habits of the individual lead the medical health officer to decide that risk of transmission is low.

(2) A contact shall be excluded from occupations involving the handling of food or milk, or the care of children, the sick, elderly or dependent, until 2 stool specimens, taken not less than 24 hours apart, are reported as negative, unless the sanitary habits of the individual lead the medical health officer to decide that risk of transmission is low.

16 Tuberculosis
Isolation procedures:

(1) Respiratory isolation procedures shall apply to a person with pulmonary tuberculosis in an infectious form.

(2) Cutaneous isolation procedures shall apply to a person with cutaneous tuberculosis lesions.

Quarantine: none.

Special measures:

(1) A contact within the family shall have initial testing for evidence of infection with tuberculosis.

(2) A contact outside the family shall have initial testing for evidence of infection with tuberculosis at the discretion of the medical health officer or of the Director of the Division of Tuberculosis Control of the Ministry of Health.

17 Typhoid Fever and Paratyphoid Fever
Isolation procedures: Enteric isolation procedures shall apply until 3 successive stool and urine specimens from the patient, taken not less than 24 hours after discontinuing antibiotics are reported as negative by a microbiologist or for a period of 21 days, whichever is the shorter.
Quarantine: none.

Special measures:

(1) A patient, on release from isolation, shall remain under surveillance and shall be excluded from occupations involving the handling of food or milk, or the care of children, the sick, elderly or dependent, until 3 consecutive stool and urine specimens from the patient, taken over a 2 week period following the end of isolation, are reported as negative by a microbiologist; but if the patient still excretes S. typhi or S. paratyphi 12 months from the onset of disease, he shall be declared a carrier.

(2) A contact of typhoid fever or paratyphoid fever shall not serve or handle food intended for distribution to anyone other than his immediate family until 3 consecutive stool and urine specimens obtained from the contact, taken not less than 24 hours apart and in the absence of recent antibiotic or chemotherapeutic treatment, have been examined by the Division of Laboratories and have failed to reveal salmonella typhi or paratyphi.

(3) The medical health officer shall place a contact under surveillance for the duration of the incubation period if the time of exposure is known.

Typhoid Carriers and Paratyphoid Carriers:

Special Measures:

(1) A carrier of typhoid fever or paratyphoid fever shall

(a) be excluded from occupations involving the handling of food or milk, or the care of children, the sick, elderly or dependent, unless the sanitary habits of the individual lead the medical health officer to decide that risk of transmission is low,

(b) remain under the surveillance of the medical health officer, and

(c) give advance notice in writing of any change of address to the medical health officer, who will immediately forward this information to the Provincial health officer.

(2) A carrier may be released from surveillance and restriction by a medical health officer, provided cultures of 6 specimens of feces or urine, taken not less than 24 hours apart, have been reported as negative by a microbiologist.

18 Viral Hemorrhagic Fevers
Isolation procedures: strict isolation procedures shall apply.
Quarantine: intimate contacts shall be quarantined for a period of 21 days in a manner that the medical health officer may direct.

Special measures:

(1) Whenever a medical health officer has reasonable grounds to suspect that a person is suffering from a viral hemorrhagic fever, the medical health officer shall immediately contact the Provincial health officer for direction respecting the place of isolation.

(2) Subject to the circumstances of the case, the Provincial health officer shall direct the medical health officer to

(a) isolate and arrange for treatment, in a suitable location, of the person suffering from a viral hemorrhagic fever and this may include arranging transportation to

(i) a designated hospital, or

(ii) a facility designated for the treatment of viral hemorrhagic fevers under agreement with the government of Canada, and

(b) ensure that no specimens for diagnostic or other purposes are taken from a person, except with the approval of and in accordance with the instructions of the medical health officer.

 

Schedule E

[Section 20]

[en. B.C. Reg. 84/97; am. B.C. Regs. 209/97; 281/2004.]

List of Designated Places

1 Any hospital as defined in section 1 of the Hospital Act is designated as a place under section 11 (4) (e) of the Health Act for the purposes of detaining a person with a reportable communicable disease.

2 The following sites are designated as places under section 11 (4) (e) of the Health Act for the purpose of detaining a male person with tuberculosis:

Cells AS.01 and AS.02
North Fraser Pretrial Centre
1451 Kingsway Avenue
Port Coquitlam, British Columbia
V3C 1S2;

Medical Isolation Unit, Rooms 225, 226, 227
Surrey Pretrial Services Centre
14323 — 57th Avenue
Surrey, British Columbia
V3X 1B1

3 The following site is designated as a place under section 11 (4) (e) of the Health Act for the purpose of detaining a female person with tuberculosis:

Segregation 1, Rooms 201, 202, 203
Surrey Pretrial Services Centre
14323 — 57th Avenue
Surrey, British Columbia
V3X 1B1

[Provisions relevant to the enactment of this regulation: Health Act, R.S.B.C. 1996, c. 179, sections 1, 8, 11 (4) (e), 12 and 16; Freedom of Information and Protection of Privacy Act, R.S.B.C. 1996, c. 165, section 33 (d)]